Skip to contentS
SkinHealth Systems Inc.
S
SKINSkinHealth Systems Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$96.82M$96.82Mderived−1.3% vs Q4 2022 Net Income-$9.40M-$9.40MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SkinHealth Systems Inc. · CIK 1818093 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$45,686,000−31.3% Operating Incomederived-$18,360,000N/M Operating Cash Flowderived-$5,170,000N/M Free Cash Flowderived-$5,198,000N/M Margins · derivedGross margin47.2%−20.6 pt vs Q4 2022
Operating margin-19.0%−16.5 pt vs Q4 2022
Net margin-9.7%−16.4 pt vs Q4 2022
ended Dec 31, 2023 · filed Mar 12, 2024 · 72 d after period end